Zivo Bioscience - Common Stock, par value $.001 per share (ZIVO)
CUSIP: 98978N101
Q2 2023 13F Holders as of 30 Jun 2023
- Type / Class
- Equity / Common Stock, par value $.001 per share
- Shares outstanding
- 3,908,612
- Total 13F shares
- 34,250
- Share change
- -3,916
- Total reported value
- $82,885
- Price per share
- $2.42
- Number of holders
- 2
- Value change
- -$11,570
- Number of buys
- 1
- Number of sells
- 1
Quarterly Holders Quick Answers
What is CUSIP 98978N101?
CUSIP 98978N101 identifies ZIVO - Zivo Bioscience - Common Stock, par value $.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 98978N101:
Top shareholders of ZIVO - Zivo Bioscience - Common Stock, par value $.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
—
class O/S missing
|
276,623
|
$846,466 | — | 31 Mar 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
—
class O/S missing
|
109,339
|
$336,764 | — | 31 Mar 2023 | |
| Warberg Asset Management LLC |
13F
|
Company |
—
class O/S missing
|
112,163
|
$65,346 | — | 31 Mar 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
—
class O/S missing
|
15,619
|
$48,107 | — | 31 Mar 2023 | |
| Column Capital Advisors, LLC |
13F
|
Company |
0.31%
|
12,000
|
$36,960 | — | 31 Mar 2023 | |
| Verdence Capital Advisors LLC |
13F
|
Company |
—
mixed-class rows
|
20,000
mixed-class rows
|
$36,626 | — | 31 Mar 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
—
class O/S missing
|
11,316
|
$34,854 | — | 31 Mar 2023 | |
| Ayrton Capital LLC |
13F
|
Company |
—
class O/S missing
|
48,850
|
$28,460 | — | 31 Mar 2023 | |
| CVI Holdings, LLC |
13F
|
Company |
—
class O/S missing
|
16,108
|
$9,504 | — | 31 Mar 2023 | |
| BARTLETT & CO. WEALTH MANAGEMENT LLC |
13F
|
Company |
—
class O/S missing
|
1,000
|
$3,080 | — | 31 Mar 2023 | |
| Bartlett & Co. LLC |
13F
|
Company |
—
class O/S missing
|
1,000
|
$3,000 | — | 31 Mar 2023 | |
| UBS Group AG |
13F
|
Company |
—
class O/S missing
|
850
|
$2,618 | — | 31 Mar 2023 | |
| PNC FINANCIAL SERVICES GROUP, INC. |
13F
|
Company |
—
class O/S missing
|
629
|
$1,937 | — | 31 Mar 2023 | |
| Belpointe Asset Management LLC |
13F
|
Company |
—
class O/S missing
|
95
|
$293 | — | 31 Mar 2023 | |
| BOURGEON CAPITAL MANAGEMENT LLC |
13F
|
Company |
—
class O/S missing
|
31
|
$96 | — | 31 Mar 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
—
class O/S missing
|
28
|
$86 | — | 31 Mar 2023 | |
| Andrew A. Dahl |
3/4/5
|
President / CEO, Director |
—
class O/S missing
|
376,000
|
— | — | 21 Oct 2021 |
Institutional Holders of Zivo Bioscience - Common Stock, par value $.001 per share (ZIVO) as of Q2 2023
As of 30 Jun 2023,
Zivo Bioscience - Common Stock, par value $.001 per share (ZIVO) was held by
2 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
34,250 shares.
The largest 2 holders included
Schechter Investment Advisors, LLC and Column Capital Advisors, LLC.
This page lists
2
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
1
Q2 2023 holders
2
Holder diff
1
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.